Competition authorities receive AstraZeneca merger filings

Report this content

COMPETITION AUTHORITIES RECEIVE ASTRAZENECA MERGER FILINGS Filings for competition law approval of the AstraZeneca merger have been made to the European Commission and the Federal Trade Commission in the U.S., it was announced today. Both regulatory bodies received the filing last Friday (January 15). They will consider the proposed merger of equals between Zeneca, a UK-based company, and Astra, of Sweden, announced last month. Contact persons: Staffan Ternby, Vice President, PR & Information, Astra AB, +46 8 553 261 07 Mikael Widell, Press Officer, PR & Information, Astra AB, +46 8 553 264 28 Michael Olsson, Manager, Investor Relations, Astra AB, +46 8 553 259 52 Jörgen Winroth, Investor Relations U.S., Astra AB,+1 609 896 4148 ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/1999/01/18/19990118BIT00300/bit0001.pdf http://www.bit.se/bitonline/1999/01/18/19990118BIT00300/bit0002.doc

Documents & Links